ADVAIR HFA - 0173-0716-20 - (fluticasone propionate and salmeterol xinafoate)

Alphabetical Index


Drug Information of ADVAIR HFA

Product NDC: 0173-0716
Proprietary Name: ADVAIR HFA
Non Proprietary Name: fluticasone propionate and salmeterol xinafoate
Active Ingredient(s): 115; 21    ug/1; ug/1 & nbsp;   fluticasone propionate and salmeterol xinafoate
Administration Route(s): RESPIRATORY (INHALATION)
Dosage Form(s): AEROSOL, METERED
Coding System: National Drug Codes(NDC)

Labeler Information of ADVAIR HFA

Product NDC: 0173-0716
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021254
Marketing Category: NDA
Start Marketing Date: 20080929

Package Information of ADVAIR HFA

Package NDC: 0173-0716-20
Package Description: 120 AEROSOL, METERED in 1 INHALER (0173-0716-20)

NDC Information of ADVAIR HFA

NDC Code 0173-0716-20
Proprietary Name ADVAIR HFA
Package Description 120 AEROSOL, METERED in 1 INHALER (0173-0716-20)
Product NDC 0173-0716
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name fluticasone propionate and salmeterol xinafoate
Dosage Form Name AEROSOL, METERED
Route Name RESPIRATORY (INHALATION)
Start Marketing Date 20080929
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Strength Number 115; 21
Strength Unit ug/1; ug/1
Pharmaceutical Classes Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]

Complete Information of ADVAIR HFA


General Information